Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00541684 | Health Assessment Study (0954-946) | PHASE3 | COMPLETED | 143 | — | — | Jul 11, 2001 | Jan 23, 2003 | Aug 15, 2024 | - | — |
| Name | Type | Description |
|---|---|---|
| MK0954, /Duration of Treatment : 16 Weeks | DRUG | - |
| Comparator : atenolol /Duration of Treatment : 16 Weeks | DRUG | - |
Inclusion Criteria: * Newly diagnosed with mild to moderate hypertension\\ * Married male in stable heterosexual relationship * No prior history of sexual dysfunction * Satisfied with overall sex life * Patient's spouse is in close proximity for the study * Has had at least 2 but not more than 10 s...